Archive for July, 2011

Subhasish Chakraborty of DTDC awarded as the Entrepreneur of the Year in Consumer Business category at the Entrepreneur India Awards 2011

Thursday, July 28th, 2011

At the recently held Entrepreneur India Awards 2011, DTDC Courier & Cargo Ltd’s CMD Mr. Subhasish Chakraborty was awarded as the Entrepreneur of the Year in the Consumer Business category. This award ceremony was organized by Franchise India so as to commend those individuals who have contributed significantly towards the growth of entrepreneurship in our country. NASSCOM Emerge Forum and Entrepreneur India Advisors were the knowledge partners for the occasion.

genuine payday loanspayday loan stores in denver colorado

Awardees were nominated after a rigorous selection process wherein nominations were received from established as well as budding entrepreneurs from all parts of the country. On receiving this prestigious award, Mr. Subhasishi Chakraborty expressed his delight by saying, “The initiative taken by Franchise India in awarding the entrepreneurs in various fields is very encouraging to both young and budding entrepreneurs as well as the established entrepreneurs. We at DTDC are elated on the achievement and the recognition bestowed upon us for our contribution to the industry in order to “Make Life Easy” for the consumers. It has enthused us to continue our innovative products and best services. Recognition from such a highly prestigious institute helps organizations to increase their franchise network by giving entrepreneurial opportunities to thousands.”

The awards ceremony was a part of Entrepreneur India 2011, a two day national conference which was organized to serve as a platform for the young and aspiring entrepreneurs to get a better understanding of entrepreneurship, innovation and how to unleash the creative potential in individuals, companies and regions.

Commenting on Entrepreneur India Awards 2011, Mr. Gaurav Marya (President, Franchise India Holdings Limited) said, “Individuals like Mr. Subhasish Chakraborty, with their passion and out-of-the-box thinking, have changed the way entrepreneurship is perceived in our country. Through these awards we want to recognize and felicitate these entrepreneurs and give them their due recognition. Hopefully, others will be inspired by them to take that one requisite step towards making their entrepreneurial dreams come true.”

World Chess Federation’s President Mr. Kirsan Ilyumzhinov was the Chief Guest for the occasion. Entrepreneur India Awards 2011 also witnessed scintillating performances by singer Shibani Kashyap and Angels Dance Troupe.getting clomid online

China International Regimen(Healthcare) Expo, 2011

Thursday, July 28th, 2011

Review?
The last China?Beijing?International Regimen Expo attracted more than 200 exhibitors from 5 countries and 34 Chinese provinces or regions. The foreign exhibitors reached 8. The exhibition area covered more than 10,000?. 23 embassies to China and 16,423(15,876 Chinese, 547 foreigners) professional visitors from 15 countries have witnessed unprecedented event together! The expo has reached professionalization, internationalization, brandization. With the improvement of service quality and management level, under the support of professionals, the regimen expo will become the biggest Asian expo with best effect and most popular event in health field.
getting cialis from canada

fake payday loan collection scamsgeneric levitra

Second Annual- Translating Oncology Therapies from the Lab to Proof of Concept

Wednesday, July 27th, 2011

Strategic Early Development Planning & Management to Avoid High Failure Rates in Innovative Cancer Therapeutics

payday loans online in texasviagra in indiabuying viagra online uk

Conference Dates: 12-13th October, 2011
Venue: Vienna, Austria

When running early clinical trials for experimental new drugs across a range of therapeutic areas, demonstrating “proof of concept” is a critical milestone of the development process, yet one that is very difficult to achieve. It is at this stage where exploratory studies become confirmatory studies and there is a basis for studying the efficacy in a larger population.

Due to the prevalence, diversity and complexity of cancer, oncology clinical trials have evolved along a different path than trials for other therapeutic areas and trial failure rates are amongst the highest amongst all therapy areas. The toxicity ratings, patient recruitment and stratification, and the regulatory and ethical aspects are all challenging considerations specific to oncology trials.

It is widely acknowledged that the current oncology clinical trial system is in desperate need of new breakthroughs as costs are increasing, and the regulatory authorities impose more extensive and complex regulatory guidelines. In recent years, the regulatory bodies have become more receptive to more advanced phase 0 micro-dosing studies, as well as adaptive clinical trials where predetermined modifications can occur in an ongoing study. Challenges in accelerating the proof of concept of oncology drugs include knowing how to integrate multiple disciplines and the latest scientific techniques and weighing the demand made by different stakeholders to make logical decisions earlier with the right information.

This two day event will showcase essential industry, scientific, ethical, academic and regulatory perspectives regarding the latest and most critical issues surrounding early-phase oncology drug development. Experts in the field will talk about their experiences in the pre-clinical, translational and clinical development and how they created a program that satisfies all stakeholders.

Attendees of this event will learn how to utilize resources and the latest science and satisfy major regulations to efficiently translate laboratory theories into clinical practice and achieve proof of concept for innovative oncology therapeutics.

Why Attend?
• Discover the most efficient methods of creating an advanced pre-clinical and translational program to understand disease biology and drug mechanism of action and to obtain approval for FIH studies
• Meet highly experienced experts that are directly involved in anti-cancer agent clinical trial design and implementation.
• Learn about the regulatory requirements in North America and Europe for small and large molecules.
• Work-out the best ways of integrating advanced biomarkers, delivery systems, modelling & simulation, micro-dosing and adaptive trials into your clinical programs.

Who will benefit?
Experienced executives from Pharma, Biotechs and Academia involved in:
oncology drug development

VPs, Professors, Senior Directors and Managers involved in:
biologics, small molecules, discovery, pre-clinical development, exploratory development, early phase clinical development, clinical operations, clinical science, clinical pharmacology, biomarkers, senior scientists, licensing, translational medicine, regulatory affairs, therapy area heads, and R&D.

Agenda request
To request the full agenda please follow the link:

http://www.nextlevelpharma.com/events/view/2nd_annual_translating_oncology_therapies_from_the_lab_to_proof_of_concept

For Booking Information contact:
Erika Vavrovicova

Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: www.nextlevelpharma.com

Approved by the World Energy Council- Africa Energy Indaba signs official agreement with WEC and SANEA

Wednesday, July 27th, 2011

prednisone 20 mg

cash advance belvidere il

The Africa Energy Indaba has officially partnered with the South African National Energy Association (SANEA) and the World Energy Council (WEC). Chairman of SANEA and the Conference Chairman of the African Energy Indaba, Brian Statham, Secretary General of the World Energy Council , Dr Christophe Frei and CEO and owner of the African Energy Indaba , Liz Hart, formalised this highly anticipated partnership on 6 June 2011.

payday loans in pa direct lenders ordering cialis

The WEC is the foremost multi-energy organisation in the world today. WEC has member committees in nearly 100 countries throughout the world, including most of the largest energy-producing and energy consuming countries, focusing on all types of energy including coal, oil, natural gas, nuclear, hydro, and renewables. The SANEA is the South African member committee of the WEC, representing a hub for the exchange of energy related information as well as is the largest energy industry association in Sub-Saharan Africa, representing all energy companies.

The African Energy Indaba is innovative in their approach to ensuring the conference addresses issues of importance and that are current in the energy sector in Africa. This approach stems from the formation of a steering committee comprising industry experts hand-picked from across the industries with a predetermined view on who should present on current topical issues ensuring the provision of a professional product in the form of a world class event. This way, the forum is unique in its approach with a diversity of industry professionals well versed on energy issues as well as issues requiring attention. As such, the programme is always relative to the African energy community year on year. The first committee meeting convened on 6 July 2011 to finalise the programme for the upcoming event.

The African Energy Indaba Steering Committee is represented by:

Brian Statham, SANEA Chairman; Shaun Nel, Programme Director for the Energy Intensive Users Group (EIUG); Anthony Golding, South African Department of Energy (DoE); Avhapfani Tshifularo, South African Petroleum Industry Association (SAPIA); Barry Bredenkamp, National Energy Efficiency Association (NEEA); Elsa Du Toit, SAHA International; Greg Nott, International lawyer, Jonathan de Magalhaes, Ubuntu Energy; Dr Latsoucabe Fall, WEC Africa and Professor Mosad Elmissary, NEPAD Agency.

The Africa Energy Indaba will serve as a platform to discuss Africa’s energy future, coming up with innovative solutions on how Africans can meet the increasing demand for energy and how this can all be done in a cost effective and efficient manner.

ENDS
26 July 2011

Prepared by: Siyenza Management
011 463 9184
celine@siyenza.za.com

On behalf of: Africa Energy Indaba (AEI)
Contact: Liz Hart
liz@siyenza.za.com

About Africa Energy Indaba 2012
The Africa Energy Indaba takes place from February 21 to 23 2012 at the Sandton Convention Centre, Johannesburg, South Africa. The event brings together stakeholders from the global energy industry and the financial community, including energy providers, engineers, financial service providers, economists, government representatives and media. Visit www.energyindaba.co.za

About the World Energy Council www.worldenergy.org

About the South Africa National Energy Association www.sanea.org.za

Kind Regards

Pricing and Reimbursement in The United Kingdom during Significant Healthcare Reform

Monday, July 25th, 2011


Demonstrating product value to NICE, NHS trusts & key opinion leaders

Conference Dates: 5-6th October, 2011
Venue: London, UK
The UK Coalition Government has recently initiated a significant healthcare reform which in reality, presents both major challenges and opportunities to payers, policy-makers and the pharmaceutical industry.

payday loans interest rate

The main components that will affect the pharmaceutical industry include a shift in the role of N.I.C.E. from the gatekeeper of market access to making strong, yet non-binding recommendations regarding cost-effectiveness of treatments. Decisions will be decentralized and delegated to the local-level as “GP Consortia”, who are closer to the patient will be empowered to reimburse based on local need. Furthermore, the existing Pharmaceutical Pricing & reimbursement Scheme (PPRS) will expire and the move will be made to an ambitious value-based pricing model from 2014. For the NHS too, value-based pricing can help to encourage that future applications for reimbursement and premium prices will only be met if the therapy will treat real public health concerns for a rapidly ageing population, improve quality of life and keep patients out of expensive hospital treatments and the burden on health budgets.

Current patient-access (risk-sharing) models may no longer fit under the new decentralised healthcare system and pharmaceutical companies in the UK are restructuring commercial operations to adjust access schemes to new models and decision-making processes.

This event will not only describe current and upcoming healthcare reforms but will also clarify how market-access and reimbursement decisions might proceed and with what effects.

Why Attend?
• Focus on the most influential European market, that is central to global pricing strategy and a traditional pioneer in health technology assessment.
• Evaluate how pricing and reimbursement will be affected under the on-going NHS reform.
• Hear policy makers’ and payers’ views, initiatives and incentives on how the system will work in practice.
• Learn how innovation will be measured and rewarded in the UK in the near future.
• Understand all stakeholders’ roles in the increasingly decentralised decision-making process in the new healthcare reform.
• Find out more about the value-based pricing initiatives and their affect on pricing, market access and competition.
• Network with key decision makers who are involved in designing and implementing this significant reform.

Who will benefit?
Pharmaceutical and Medical devices companies:
Vice-Presidents, Directors, Managers involved in:
Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Market Access, Country Managers
Solution providers & consultants:
CEOs, Business Development, Senior Consultants, Regional Heads
Independent Academics, Health Economists, Government Officials, Public & Private Healthcare Providers, Senior Doctors, &Patient Representatives.

Agenda request
To request the full agenda please follow the link:

http://www.nextlevelpharma.com/events/view/pricing_reimbursement_in_the_united_kingdom_during_significant_healthcare_reform

For Booking Information contact:
Erika Vavrovicova

Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: www.nextlevelpharma.com
levitra tab 20mgcash advance in royal oak

Text Analytics World Topics & Case Studies Announces NYC Speaker Line Up

Thursday, July 21st, 2011

Text Analytics World Topics & Case Studies – Oct 19-20 in NYC

Text Analytics World NYC (tawgo.com) is the business-focused event for text analytics professionals, managers and commercial practitioners. This conference delivers case studies, expertise and resources to leverage unstructured data for business impact.

payday loans hanover park il, personal injury cash advancecheapest overnight cialis

Text Analytics World NYC is packed with the top predictive analytics experts, practitioners, authors and business thought leaders, including keynote addresses from Thomas Davenport, author of Competing on Analytics: The New Science of Winning, David Ferrucci from IBM Research on their Jeopardy-Winning Watson and DeepQA, and PAW Program Chair Eric Siegel, plus special sessions from industry heavy-weights Usama Fayyad and John Elder.

CASE STUDIES:
TAW New York City will feature over 25 sessions with case studies form leading enterprises in automobile, educational, e-commerce, financial services, government, high technology, insurance, retail, social media, and telecom such as: Accident Fund, Amdocs, Bundle.com, Citibank, Florida State College, Google, Intuit, MetLife, Mitchell1, PayPal, Snap-on, Socialmediatoday, a Fortune 500 global technology company, plus special examples from U.S. government agencies DoD, DHS, and SSA.

HOT TOPICS:
TAW New York City’s agenda covers hot topics and advanced methods such as churn risk detection, customer service and call centers, decision support, document discovery, document filtering, financial indicators from social media, fraud detection, government applications, insurance applications, knowledge discovery, open question-answering, parallelized text analysis, risk profiling, sentiment analysis, social media applications, survey analysis, topic discovery, and voice of the customer and other innovative applications that benefit organizations in new and creative ways.

For more information: tawgo.com

View the agenda at-a-glance: textanalyticsworld.com/newyork/2011/agenda

Register by September 2nd for Early Bird Rates (save up to $200): textanalyticsworld.com/newyork/2011/registration

If you’d like our informative event updates, sign up at:

http://www.textanalyticsworld.com/subscription.php

To sign up for TAW group on LinkedIn:
www.linkedin.com/e/gis/3869759

For inquiries e-mail regsupport@risingmedia.com or call (717) 798-3495.

OTHER ANALYTICS EVENTS:
Predictive Analytics World for Government: Sept 12-13 in DC – www.pawgov.com
Predictive Analytics World New York City: Oct 16-21 – www.pawcon.com/nyc
Text Analytics World New York City: Oct 19-20 – www.tawgo.com/nyc
Predictive Analytics World London: Nov 30-Dec 1 – http://www.pawcon.com/london
Predictive Analytics World San Francisco: March 4-10, 2012 – www.pawcon.com/sanfrancisco
Predictive Analytics World Videos: Available on-demand – www.pawcon.com/video

RAILWORLD SUMMIT 2011 to be held in Beijing

Thursday, July 21st, 2011

CDMC will be presenting the RAILWORLD SUMMIT 2011 to be held in Beijing, China on the 21-23 Sept 2011. It will be a one-stop platform to discuss the future of emerging rail market, including planning, expansion, execution, project funding, day-to-day operations, round-the-clock maintenance, civil & construction works, power & electrification, track modernization, cutting-edge technologies of signaling, rolling stocks and other pertinent case studies in High Speed railway and Metro.
Staying on top of rapid developments in High Speed Rail, ‘RAILWORLD SUMMIT’ features an exclusive High Speed Rail Day on the first day – 22nd Sept 2011 to examine the new project, Operation and maintenance and new business opportunities to make High Speed Rail a reality.

payday loans online direct lenders, payday loans lenders not brokers no credit checkbuying viagra in uk

You will hear from:
YANG Zhongmin, Director-General of Development and planning, Ministry of Railways China
LI Guoyong, Deputy Director-General of Department of Basic Industries, National Development and Reform Commission, PRC
Robert Wihtol, Country Director, Asian Development Bank PRC
Alex Toursky, First Deputy General Director, JSC High-Speed Rail Lines
Ou Chin-Der, Chairman and Chief Executive Officer, Taiwan High Speed Rail Corporation
Jean-Michel Dancoisne, Permanent Representative, SNCF, Belgium
David Kerr, Chief Executive Officer, Toll Royal Railway
Hilmi Hasan, GM – Finance, KTMB
Sim Wee Meng, Group Director, Rail, Land Transport Authority, Singapore
Shahid Ahmed, General Manager, Manufacturing and Services, Pakistan Railways
Julison Arifin, Director of Business Development, Indonesian Railways
Gopal R, Vice President, Asia Pacific Transportation & Logistics Practice, Frost & Sullivan
Lam Soi Hoi, Technical Consultant, Transportation Infrastructure Office (GIT), the Government of Macau S.A.R.
Ulrich Koegler, Vice President, Booz & Company
Bhupinder Singh Bedi, PPP Expert, ASIAN DEVELOPMENT BANK
And more

This event is proudly supported by Ministry of Railways PRC, Indian Railways, American Railway Engineering and Maintenance-of-Way Association, Asia Infrastructure and The Project Management Institute Malaysia Chapter.
For more information, please visit www.cdmc.org.cn/railworld

Unmet Medical Need Forum

Wednesday, July 20th, 2011

best payday loan online

Preparing for the drug therapies required to combat tomorrow’s illnesses of high socioeconomic impact

ordering real viagra from canada

Conference Dates: 4-5th October, 2011
Venue: London, UK

It is now widely known that healthcare systems around the world are already under significant budgetary pressure, with the prognosis for the future looking far from positive. Ageing populations, growing incidents of chronic disease that effect large patient populations, costly acute specialty conditions, expensive treatments for rare-diseases and the widespread use of more effective, yet expensive drugs and technologies are some of the main drivers. Governments are well aware that investing in a healthier population results in a richer and happier population. Medicines that can dramatically improve quality of life can help to keep patients out of expensive hospital care and often back into the workforce as productive members of society.

The economic value of such treatments are often exceptional and easily measurable. Despite years of health reform and cost-containment policy implementation, only some of the symptoms have been treated effectively, but the underlying cause needs urgent attention before costs for payers spiral out of control. There often seems to be a disconnect between what therapies payers and policy makers need and see as public health priorities worthy of investment and what products pharma companies and medical manufacturers are bringing to the market. Drug developers take extreme risks in bringing new drugs to the market, spending over a billion dollars per therapy and investing over 10 years on average in R&D time and still face very high failure rates. This investment needs to be more targeted at least to the areas that payers define as unmet need and of high value for such extreme risks to be worthwhile taking. Considerable progress has been made on both sides, with payers increasingly “scanning horizons” to find out what drugs and devices will affect their budgets in the coming years, whilst manufacturers have paid much more attention to receiving scientific advice from payers earlier in the clinical trials process.

There is also confusion with regards to the definition of “innovation” and how much payers are willing to invest in “innovations”. Novel classes of small and large molecules with exciting mechanisms of action may only have slight therapeutic benefits over existing drugs, whilst “incremental innovations” of older drugs could alternatively also improve outcomes at significantly less cost. A solid understanding of what “innovations” are required for the public good is a question that needs to be answered today so that industry can develop the drug pipelines of tomorrow for the benefit of society.

Why this event?
• Discuss payers and policy makers views regarding their disease indications and public health investment priorities today and in the future.
• Understand what are the payer’s priorities to make long-term R&D investment decisions.
• Learn what are products that payers want to pay for and will generate return on investment.
• Help encourage medical “innovation” and to improve patient access to high-value medications and devices.

Who will benefit?

PAYERS & POLICY MAKERS: Senior representatives from Payers, health plans & insurers, Public health experts, health technology assessors, hospital financial management, government & health ministry officials, health management and managed care organizations, epidemiology, horizon scanning, scientific advice, pharmacy strategy & budget management.
INDUSTRY: Corporate senior management, strategic marketing, portfolio strategy & management, corporate & business development health economics, outcomes and market access, epidemiology, health policy, government and stakeholder relations, chief medical officers, R&D strategy, financial strategy.
OTHER STAKEHOLDERS: Regulatory agencies, key-opinion-leaders, independent health economists, health researchers and academics, physicians, patient groups.

Agenda request
To request the full agenda please follow the link:
http://www.nextlevelpharma.com/events/view/unmet_medical_need_forum

For Booking Information contact:
Erika Vavrovicova

Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: www.nextlevelpharma.com

Upcoming World Smart Grid India Week 2011 to Address Key Challenges and Issues for India Smart Grid Roll-out

Tuesday, July 19th, 2011

India, the largest democratic state, has the fifth largest electricity grid and third largest Transmission & Distribution network respectively in the world. However, due to the dramatically increasing economic activities and rising electricity consumption, there has been a significant challenge to face for Indian government. Origins of India’s smart grid efforts are multi-factorial in nature but primarily concern three main issues which are the subject of current or planned government backed initiatives: 1) Balance the supply and demand of the power market; 2) Electrify a large segment of its rural population to receive electrical services; 3) Optimize electrical usage by being able to manage loads and mitigate operating inefficiencies. Furthermore, central government involvement in the smart grid has expanded beyond the confines of Ministry of Power into an inter-department task force known as India Smart Grid Task Force.

usa payday loans locations

viagra best buy

payday loan over 12 months

“Under my stewardship, we wish to evolve a future roadmap for development of Smart Grid in India aided by the most modern and latest technologies in the field.” said by Shri Sam Pitroda, the Chairman of India Smart Grid Task Force who is confirmed to be the opening keynote speaker of World Smart Gird Conference Series India Week. He is planning to present the role of India Smart Grid Task Force, national smart grid initiatives, and India’s smart grid roadmap and strategy in the environment of emerging economic.

Meantime, Dr. Pramod Deo, Chairman of Central Electricity Regulatory Commission which takes responsible of tariff, legal and regulatory issues, will present the regulatory challenges and opportunities for India Smart Grid.

Not only two senior speakers above, but also some main local utilities, such as Bangalore Electricity Supply Company (BESCOM), Reliance Infrastructure, NDPL, APCPDCL, and BSES have also be arranged to speak in this event for their own perspectives towards smart grid.

World Smart Grid Conference Series-India Week 2011, to be held on September 13th to 16th in Mumbai, is a unique event for you to attain deep understandings on India’s smart grid initiatives, roadmap, regulatory environment, ongoing pilots of local utilities, network local and international smart grid industry executives and share insights on the future market developments.

The conference is vendor-neutral, product-neutral, and platform-neutral with highly intense interaction between delegates, and allows for real discussion and debate, not simply a series of “product presentations”.

Eminent Speakers Confirmed:
? Sam Pitroda, Chair, India Smart Grid Task Force
? Pramod Deo, Chairman, Central Electricity Regulatory Commission
? V. K. Shah, Executive Director (APDRP), Power Finance Corporation
? Narendra Singh Sodha, Executive Director, Power Grid Corporation of India
? Ramesh Narayanan, CEO, BSES Yamuna Power Limited
? Sunil Wadhwa, Managing Director, NDPL
? Ajoy Rajani, Vice President, Reliance Infrastructure
? Abhijit Roy, Head – New Technology Initiatives, Reliance Infrastructure
? Jacob Joseph, Deputy General Manager, TATA Power
? Amit Prasad, Director of Smart Grid, New Delhi Municipal Counci
? Jayant Deo, CEO and Managing Director, India Energy Exchange
? Claudio Lima, Vice Chair, IEEE P2030 Smart Grid Architecture
? Ashish Khanna, Senior Energy Specialist, South Asia Sustainable Development, World Bank
? Monali Zeya Hazra, Program Management Specialist, USAID
? Norbert Karl, Global Sales & Business Development Smart Grid, Siemens
? Larry Kraft, Senior Vice President, Digi International
? Manu Rishi Puri, Sr Managing Consultant?IBM – Global Business Services
? Somnath Chatterjee, Head – Energy, Utilities and Chemicals CoE, Capgemini
? Senior Executive, Schneider Electric
? Senior Executive, National Instruments

Organizing Committee of World Smart Grid Conference Series India Week 2011
Media contact person: Miss Viola Yan
Tel: +86 21 5830 0710
Fax: +86 21 5831 1668
E-mail: info@szwgroup.com
Website: www.szwgroup.com/2011/sgindia
discount levitra online us

Human Capital & Talent Management Forum 2011

Monday, July 18th, 2011

Human Capital & Talent Management Forum 2011 will be convened in Pullman Oceanview Sanya Bay Resort & Spa, October 26-27th 2011. This is the most prestigious Human Resource event in China, which brings you the latest in cutting-edge HR solutions as well as excellent networking opportunities which contribute to the creation of numerous successful partnerships as well as support from our sponsors, exhibitors and media partners. HR 2011 plans to provide the most exciting developments and offerings for the HR industry!

payday loans for prepaid cards payday one loans online

purchase cialis cheap

Strong support has come from the whole industry, so far we have confirmed the following speakers and a few more are coming soon.

payday loans in kitchener ontario payday loans online no faxing no credit checklevitra brand discount

Wells Tian, Head consulting from Aon Hewitt
Tad Waddington, Director of PM from Accenture
Oliver Chen Senior HR director from Alibaba
Shanthi Flynn, Senior People Director from Wal-Mart
Martin Lebek ,Senior HR VP from Novartis
Claire Yu, Director of OD &Learning APAC from Honeywell,
Leo Chen HR director from SK Group,
Amanda Xu, HR service center manager from Lenovo,
Gina Wu , OD and Learning Director from Baidu
Vivian Tao, Deputy GM from NYK Line
Michael Gan , Senior HR manager from CH2M HILL
Dominic Penaloza , CEO from Ushi
Gemma Ellis , Alexander Mann Solutions
James Guo , CEO from ZDL

Dedicated to moving the industry forward, Human Capital & Talent Management Forum 2011 will be an essential platform for reviewing progress and determining how the sector can take the next vital steps towards successful commercialization.

We look forward to meeting you in Sanya, Hainan, October 26th – 27th 2011.

For information please visit our website: www.hrtalentforum.com